retatrutide clinical trial results retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Retatrutide clinical trial done! Now

The new medication, a daily oral GLP-1 pill called orforglipron, which can promote weight loss in adults with obesity, demonstrates additional potential for adults who have both obesity and Type 2 diabetes

We have an amazing arsenal of medications today compared to 10 or 15 years ago, including beneficial classes beyond GLP-1s and GLP-1/GIPs, such as Qsymia (phentermine + topiramate), Contrave (naltrexone + bupropion), and metformin

Controlling/managing blood sugar is one aspect of GLP-1 meds

Trulicity is the brand name for dulaglutide, one of the earlier GLP-1 medications to be approved by the FDA for patients with type 2 diabetes

If you are unsure about your family medical history, it may be worth speaking to relatives before starting treatment

Weeks 1 through 4: establishment phase Most theoretical frameworks suggest starting tesamorelin first, alone, for 2 to 4 weeks